These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 26039946

  • 1. Efficacy of levofloxacin, amoxicillin and a proton pump inhibitor in the eradication of Helicobacter pylori in Brazilian patients with peptic ulcers.
    Silva FM, Queiroz EC, Navarro-Rodriguez T, Barbuti RC, Mattar R, Iriya K, Lee JH, Eisig JN.
    Clinics (Sao Paulo); 2015 May; 70(5):318-21. PubMed ID: 26039946
    [Abstract] [Full Text] [Related]

  • 2. Second-line levofloxacin-based triple therapy's efficiency for Helicobacter pylori eradication in patients with peptic ulcer.
    Ermis F, Akyuz F, Uyanikoglu A, Kurt R, Pinarbasi B, Nazik H, Kaymakoglu S, Mungan Z.
    South Med J; 2011 Aug; 104(8):579-83. PubMed ID: 21886067
    [Abstract] [Full Text] [Related]

  • 3. Randomized trial comparing rabeprazole- versus lansoprazole-based Helicobacter pylori eradication regimens.
    Liu MK, Wu IC, Lu CY, Kuo CH, Yu FJ, Liu CJ, Hsu PI, Hsu WH, Su YC, Chen A, Wu DC, Kuo FC, Chen JJ.
    Kaohsiung J Med Sci; 2013 Jul; 29(7):379-84. PubMed ID: 23768702
    [Abstract] [Full Text] [Related]

  • 4. Comparison of levofloxacin- and moxifloxacin-based triple therapies with standard treatment in eradication of Helicobacter pylori as first-line therapy.
    Rakici H, Ayaz T, Akdogan RA, Bedir R.
    Digestion; 2014 Jul; 90(4):261-4. PubMed ID: 25547786
    [Abstract] [Full Text] [Related]

  • 5. Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin.
    Louw JA, Van Rensburg CJ, Moola S, Kotze D, Marks IN.
    Aliment Pharmacol Ther; 1998 Sep; 12(9):881-5. PubMed ID: 9768531
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of PPI, levofloxacin and amoxicillin in the eradication of Helicobacter pylori compared to conventional triple therapy at a Venezuelan hospital.
    Dib J, Alvarez B, Mendez L, Cruz ME.
    Arab J Gastroenterol; 2013 Sep; 14(3):123-5. PubMed ID: 24206741
    [Abstract] [Full Text] [Related]

  • 7. Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients.
    Gisbert JP, Pérez-Aisa A, Bermejo F, Castro-Fernández M, Almela P, Barrio J, Cosme A, Modolell I, Bory F, Fernández-Bermejo M, Rodrigo L, Ortuño J, Sánchez-Pobre P, Khorrami S, Franco A, Tomas A, Guerra I, Lamas E, Ponce J, Calvet X, H. pylori Study Group of the Asociación Española de Gastroenterología (Spanish Gastroenterology Association).
    J Clin Gastroenterol; 2013 Feb; 47(2):130-5. PubMed ID: 22647827
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of first-line triple therapy with levofloxacin and amoxicillin plus esomeprazole or rabeprazole for the eradication of Helicobacter pylori infection and the effect of CYP2C19 genotype: a 1-week, randomized, open-label study in Chinese adults.
    Pan X, Li Y, Qiu Y, Tang Q, Qian B, Yao L, Shi R, Zhang G.
    Clin Ther; 2010 Nov; 32(12):2003-11. PubMed ID: 21118735
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and Safety of Vonoprazan-Based Quadruple Therapy for the Eradication of Helicobacter pylori in Patients with Peptic Ulcers: A Pooled Analysis of Two Randomized, Double-Blind, Double-Dummy, Phase 3 Trials.
    Hou X, Wang J, Du Q, Tian D, Hu N, Liu D, Zhou F, Xie L, Gu L, Kudou K, Zhang S.
    Biol Pharm Bull; 2024 Nov; 47(8):1405-1414. PubMed ID: 39085080
    [Abstract] [Full Text] [Related]

  • 13. Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics?
    Branquinho D, Almeida N, Gregório C, Cabral JE, Casela A, Donato MM, Tomé L.
    BMC Gastroenterol; 2017 Feb 15; 17(1):31. PubMed ID: 28202013
    [Abstract] [Full Text] [Related]

  • 14. Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients.
    Gisbert JP, Bermejo F, Castro-Fernández M, Pérez-Aisa A, Fernández-Bermejo M, Tomas A, Barrio J, Bory F, Almela P, Sánchez-Pobre P, Cosme A, Ortiz V, Niño P, Khorrami S, Benito LM, Carneros JA, Lamas E, Modolell I, Franco A, Ortuño J, Rodrigo L, García-Durán F, O'Callaghan E, Ponce J, Valer MP, Calvet X, H. pylori Study Group of the Asociación Española de Gastroenterología.
    Am J Gastroenterol; 2008 Jan 15; 103(1):71-6. PubMed ID: 17764498
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clarithromycin-based triple therapy for Helicobacter pylori treatment in peptic ulcer patients.
    Felga G, Silva FM, Barbuti RC, Navarro-Rodriguez T, Zaterka S, Eisig JN.
    J Infect Dev Ctries; 2010 Nov 24; 4(11):712-6. PubMed ID: 21252448
    [Abstract] [Full Text] [Related]

  • 20. Pilot study: miscellaneous therapy is highly successful for Helicobacter pylori eradication.
    Sierra F, Forero JD, Rey M, Botero ML, Cárdenas A.
    Aliment Pharmacol Ther; 2013 Jun 24; 37(12):1165-71. PubMed ID: 23656465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.